The Role of TMP21 in Trafficking and Amyloid-β Precursor Protein (APP) Processing in Alzheimer’s Disease

Author(s): Kelley Bromley-Brits, Weihong Song

Journal Name: Current Alzheimer Research

Volume 9 , Issue 4 , 2012

Become EABM
Become Reviewer
Call for Editor


Alzheimer’s Disease (AD) is the most common neurodegenerative disorder leading to dementia. A major neuropathological hallmark of AD is the deposition of amyloid-β protein (Aβ) in the form of neuritic plaques. Aβ is formed by the sequential cleavage of amyloid-β precursor protein (APP) by β- and γ -secretase. It was recently suggested that TMP21 is a novel member of the γ-secretase complex which negatively regulates APP cleavage at the γ-site, but does not affect cleavage of APP or Notch at the -site . In vitro knockdown of TMP21 increases Aβ production and AD patients have less TMP21 expressed in their brains, suggesting that a deficiency in TMP21 may exacerbate AD pathology. TMP21 is most commonly known for its role in vesicle trafficking. Here we present the most recent research on TMP21 in relation to AD, including TMP21’s roles in the modulation of γ-secretase activity and protein trafficking.

Keywords: TM21, trafficking, Alzheimer, dementia, hyperphosphorylated tau, ß-secretase, Protease Inhibitor, cytosis, cytoskeletal track

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 26 April, 2012
Page: [411 - 424]
Pages: 14
DOI: 10.2174/156720512800492521
Price: $65

Article Metrics

PDF: 10